Stock Price
0.37
Daily Change
-0.03 -7.50%
Monthly
8.82%
Yearly
273.74%
Q1 Forecast
0.37

Starpharma Holdings reported AUD1.71M in Sales Revenues for its fiscal semester ending in June of 2025.





Sales Change Date
Medical Developments International AUD 9.53M 1.99M Jun/2025
Mesoblast USD 13.2M 10.04M Jun/2025
Neuren Pharmaceuticals AUD 14.14M 179.96M Jun/2025